Mechanisms of macrolide resistance in clinical pneumococcal isolates in France

被引：42

作者：

Fitoussi, F

Doit, C

Geslin, P

Brahimi, N

Bingen, E

机构：

[1] Hop Robert Debre, Microbiol Serv, F-75019 Paris, France

[2] Ctr Hosp Creteil, Ctr Natl Reference Pneumocoques, F-94010 Creteil, France

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2001年 / 45卷 / 02期

关键词：

D O I：

10.1128/AAC.45.2.636-638.2001

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The genetic basis of macrolide resistance was investigated in a collection of 48 genotypically unrelated clinical isolates of Streptococcus pneumoniae obtained between 1987 and 1997 in France. All strains were resistant to erythromycin, clindamycin, and streptogramin B, exhibiting a macrolide-lineosamide-streptogramin B resistance phenotype, and harbored the erm(B) gene. None of the strains carried the mef(A) or erm(A) subclass erm(TR) gene.

引用

收藏

页码：636 / 638

页数：3

相关论文

共 25 条

[11] Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae [J].

Johnston, NJ ;

De Azavedo, JC ;

Kellner, JD ;

Low, DE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2425-2426

[12] Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae:: characterization of South African isolates [J].

Klugman, KP ;

Capper, T ;

Widdowson, CA ;

Koornhof, HJ ;

Moser, W .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (06) :729-734

[13] Macrolide resistance in Belgian Streptococcus pneumoniae [J].

Lagrou, K ;

Peetermans, WE ;

Verhaegen, J ;

Van Lierde, S ;

Verbist, L ;

Van Eldere, J .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (01) :119-121

[14] BACTERIAL-RESISTANCE TO MACROLIDE, LINCOSAMIDE, AND STREPTOGRAMIN ANTIBIOTICS BY TARGET MODIFICATION [J].

LECLERCQ, R ;

COURVALIN, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (07) :1267-1272

[15]

LECLERCQ R, 1999, LETT INFECT, V14, P16

[16] Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates [J].

Oster, P ;

Zanchi, A ;

Cresti, S ;

Lattanzi, M ;

Montagnani, F ;

Cellesi, C ;

Rossolini, GM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (10) :2510-2512

[17] Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998 [J].

Sahm, DF ;

Jones, ME ;

Hickey, ML ;

Diakun, DR ;

Mani, SV ;

Thornsberry, C .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (04) :457-466

[18]

Seppälä H, 1998, ANTIMICROB AGENTS CH, V42, P257

[19] Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995 [J].

Shortridge, VD ;

Doern, GB ;

Brueggemann, AB ;

Beyer, JM ;

Flamm, RK .

CLINICAL INFECTIOUS DISEASES, 1999, 29 (05) :1186-1188

[20] Detection of erythromycin-resistant determinants by PCR [J].

Sutcliffe, J ;

Grebe, T ;

TaitKamradt, A ;

Wondrack, L .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (11) :2562-2566